Tuesday, October 30, 2012 1:34:01 PM
Just speculating I'd say $2 - $4 would be a conservative guess but there are many other factors and possibilities that exist, especially with big pharma that could send this to $10+ IMO.
This is a very unique situation, not sure we have ever see anything quite like it on the OTC. I guess the only question is how will investors react once they hear the news, will this large Russian pharmaceutical company get treated like so many large Chinese companies do and be illiquid and insanely undervalued.....or....will investors go apechit over it because the Russian pharma industry is incredibly hot right now, with nearly every big pharma company desperate to increase their presence there..?
Only time will tell.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM